{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:24:21Z","timestamp":1795188261830,"version":"4.10.3"},"reference-count":243,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cannabidiol (CBD) is the primary non-psychoactive component of cannabis. Consumption of CBD is increasing rapidly as it is federally legal and widely available in the United States, Europe, Mexico, Canada, and Asia. CBD is gaining traction in medical and biochemical research, though a comprehensive classification of CBD receptor interactions is yet to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search across PubMed, Web of Science, and Google Scholar identified studies reporting cannabidiol (CBD) interactions with receptors, enzymes, and biological processes. Eligible articles included cell culture, animal model, biochemical, and clinical studies. Findings were thematically synthesized by body system, emphasizing mechanisms and implications for health and disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, I compile the literature to date of known interactions between CBD and various receptors, enzymes, and processes. I discuss the impact of CBD exposure on multiple processes, including endocannabinoid receptors, ion channels, cytochrome 450 enzymes, inflammatory pathways, and sex hormone regulation. I explain the potential effects of CBD on psychiatric disorders, seizure activity, nausea and vomiting, pain sensation, thermal regulation, neuronal signaling, neurodegenerative diseases, reproductive aging, drug metabolism, inflammation, sex hormone regulation, and energy homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Understanding how CBD functions and how it can interact with other recreational or pharmaceutical medications is necessary for proper clinical management of patients who consume CBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00274-y","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T09:54:18Z","timestamp":1746957258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Beyond the hype: a comprehensive exploration of CBD\u2019s biological impacts and mechanisms of action"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-7308","authenticated-orcid":false,"given":"Karli","family":"Swenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"issue":"6","key":"274_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jsps.2021.04.015","volume":"29","author":"K Alhosaini","year":"2021","unstructured":"Alhosaini K, Azhar A, Alonazi A, Al-Zoghaibi F. GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharm J. 2021;29(6):539\u201351. https:\/\/doi.org\/10.1016\/j.jsps.2021.04.015.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"274_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"S Atalay","year":"2019","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants (Basel). 2019;9(1):21. https:\/\/doi.org\/10.3390\/antiox9010021.","journal-title":"Antioxidants (Basel)"},{"key":"274_CR3","unstructured":"A Abernethy Hemp Production and the 2018 Farm Bill - 07\/25\/2019. FDA 2019 https:\/\/www.fda.gov\/news-events\/congressional-testimony\/hemp-production-and-2018-farm-bill-07252019. Accessed 22 Nov 2022"},{"issue":"6","key":"274_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5863\/1551-6776-25.6.485","volume":"25","author":"R Abu-Sawwa","year":"2020","unstructured":"Abu-Sawwa R, Scutt B, Park Y. Emerging Use of Epidiolex (Cannabidiol) in Epilepsy. J Pediatr Pharmacol Ther. 2020;25(6):485\u201399. https:\/\/doi.org\/10.5863\/1551-6776-25.6.485.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"274_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000201556","volume":"83","author":"J Ahrens","year":"2009","unstructured":"Ahrens J, Demir R, Leuwer M. The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function. Pharmacology. 2009;83(4):217\u201322. https:\/\/doi.org\/10.1159\/000201556.","journal-title":"Pharmacology."},{"issue":"4","key":"274_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ceca.2015.02.001","volume":"57","author":"RM Ali","year":"2015","unstructured":"Ali RM, Al Kury LT, Yang KHS, et al. Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. Cell Calcium. 2015;57(4):290\u20139. https:\/\/doi.org\/10.1016\/j.ceca.2015.02.001.","journal-title":"Cell Calcium"},{"key":"274_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.reprotox.2020.01.003","volume":"93","author":"M Almada","year":"2020","unstructured":"Almada M, Amaral C, Oliveira A, et al. Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling. Reprod Toxicol. 2020;93:75\u201382. https:\/\/doi.org\/10.1016\/j.reprotox.2020.01.003.","journal-title":"Reprod Toxicol"},{"issue":"6","key":"274_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.682","volume":"8","author":"DL de Almeida","year":"2020","unstructured":"DL Almeida de, LA Devi. 2020 Diversity of molecular targets and signaling pathways for CBD Pharmacol Res Perspect. 2020;8(6):e00682. https:\/\/doi.org\/10.1002\/prp2.682","journal-title":"Pharmacol Res Perspect"},{"key":"274_CR9","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/JPR.S258433","volume":"13","author":"U Anand","year":"2020","unstructured":"Anand U, Jones B, Korchev Y, et al. CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. J Pain Res. 2020;13:2269\u201378. https:\/\/doi.org\/10.2147\/JPR.S258433.","journal-title":"J Pain Res"},{"issue":"7","key":"274_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","volume":"66","author":"E Akimova","year":"2009","unstructured":"Akimova E, Lanzenberger R, Kasper S. The Serotonin-1A Receptor in Anxiety Disorders. Biol Psychiat. 2009;66(7):627\u201335. https:\/\/doi.org\/10.1016\/j.biopsych.2009.03.012.","journal-title":"Biol Psychiat."},{"key":"274_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2407-9-187","volume":"9","author":"VP Androutsopoulos","year":"2009","unstructured":"Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer. 2009;9:187. https:\/\/doi.org\/10.1186\/1471-2407-9-187.","journal-title":"BMC Cancer"},{"issue":"6","key":"274_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2045125312457586","volume":"2","author":"Z Atakan","year":"2012","unstructured":"Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012;2(6):241\u201354. https:\/\/doi.org\/10.1177\/2045125312457586.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"2","key":"274_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/can.2021.0158","volume":"8","author":"CMO de Almeida","year":"2023","unstructured":"de Almeida CMO, Brito MMC, Bosaipo NB, et al. The effect of cannabidiol for restless Legs Syndrome\/Willis-Ekbom disease in Parkinson\u2019s disease patients with REM sleep behavior disorder: a post Hoc exploratory analysis of phase 2\/3 clinical trial. Cannabis Cannabinoid Res. 2023;8(2):374\u20138. https:\/\/doi.org\/10.1089\/can.2021.0158.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"274_CR14","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1152\/ajpendo.00446.2009","volume":"298","author":"RH Amin","year":"2010","unstructured":"Amin RH, Mathews ST, Camp HS, Ding L, Leff T. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am J Physiol Endocrinol Metab. 2010;298(1):E28-37. https:\/\/doi.org\/10.1152\/ajpendo.00446.2009.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"274_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/cn3002174","volume":"4","author":"SC Altieri","year":"2012","unstructured":"Altieri SC, Garcia-Garcia AL, Leonardo ED, Andrews AM. Rethinking 5-HT1A Receptors: Emerging Modes of Inhibitory Feedback of Relevance to Emotion-Related Behavior. ACS Chem Neurosci. 2012;4(1):72\u201383. https:\/\/doi.org\/10.1021\/cn3002174.","journal-title":"ACS Chem Neurosci"},{"key":"274_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biochi.2018.10.015","volume":"161","author":"PR Albert","year":"2019","unstructured":"Albert PR, Vahid-Ansari F. The 5-HT1A receptor: Signaling to behavior. Biochimie. 2019;161:34\u201345. https:\/\/doi.org\/10.1016\/j.biochi.2018.10.015.","journal-title":"Biochimie"},{"key":"274_CR17","doi-asserted-by":"publisher","unstructured":"EP Baron. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache J Head Face Pain 2018 58(7):1139-1186 https:\/\/doi.org\/10.1111\/head.13345","DOI":"10.1111\/head.13345"},{"issue":"3","key":"274_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1124\/jpet.120.000438","volume":"377","author":"NL Brice","year":"2021","unstructured":"Brice NL, Schiffer HH, Monenschein H, et al. Development of CVN424: a selective and novel GPR6 inverse agonist effective in models of Parkinson disease. J Pharmacol Exp Ther. 2021;377(3):407\u201316. https:\/\/doi.org\/10.1124\/jpet.120.000438.","journal-title":"J Pharmacol Exp Ther"},{"key":"274_CR19","doi-asserted-by":"crossref","unstructured":"Bisogno T, Brandi I, Moriello AS, Davis JB, Mechoulam R, Marzo VD. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. 2001. p. 134\u2013845.","DOI":"10.1038\/sj.bjp.0704327"},{"issue":"9","key":"274_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1570159X18666201015155816","volume":"19","author":"S Bhatt","year":"2021","unstructured":"Bhatt S, Devadoss T, Manjula SN, Rajangam J. 5-HT3Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders. Curr Neuropharmacol. 2021;19(9):1545\u201359. https:\/\/doi.org\/10.2174\/1570159X18666201015155816.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"274_CR21","first-page":"180","volume":"42","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T. 2017;42(3):180\u20138.","journal-title":"P T"},{"issue":"4","key":"274_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ph4040603","volume":"4","author":"C B\u00e9try","year":"2011","unstructured":"B\u00e9try C, Eti\u00e9vant A, Oosterhof C, Ebert B, Sanchez C, Haddjeri N. Role of 5-HT3 Receptors in the Antidepressant Response. Pharmaceuticals (Basel). 2011;4(4):603\u201329. https:\/\/doi.org\/10.3390\/ph4040603.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"274_CR23","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1242\/jcs.080127","volume":"125","author":"T Busch","year":"2012","unstructured":"Busch T, Armacki M, Eiseler T, et al. Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. J Cell Sci. 2012;125(9):2148\u201359. https:\/\/doi.org\/10.1242\/jcs.080127.","journal-title":"J Cell Sci"},{"key":"274_CR24","doi-asserted-by":"publisher","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","volume":"14","author":"HM Blevins","year":"2022","unstructured":"Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front Aging Neurosci. 2022;14:879021. https:\/\/doi.org\/10.3389\/fnagi.2022.879021.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"274_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.bcp.2005.07.007","volume":"70","author":"TM Bland","year":"2005","unstructured":"Bland TM, Haining RL, Tracy TS, Callery PS. CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: Kinetics, pharmacogenetics and interaction with phenytoin. Biochem Pharmacol. 2005;70(7):1096\u2013103. https:\/\/doi.org\/10.1016\/j.bcp.2005.07.007.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"274_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0960-0760(99)00051-5","volume":"69","author":"A Brodie","year":"1999","unstructured":"Brodie A, Lu Q, Long B. Aromatase and its inhibitors. J Steroid Biochem Mol Biol. 1999;69(1):205\u201310. https:\/\/doi.org\/10.1016\/S0960-0760(99)00051-5.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"274_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fnins.2015.00413","volume":"9","author":"KN Browning","year":"2015","unstructured":"Browning KN. Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology. Front Neurosci. 2015;9:413. https:\/\/doi.org\/10.3389\/fnins.2015.00413.","journal-title":"Front Neurosci"},{"issue":"2","key":"274_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2006.07.090","volume":"348","author":"M Bjursell","year":"2006","unstructured":"Bjursell M, Gerdin AK, J\u00f6nsson M, et al. G protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice. Biochem Biophys Res Commun. 2006;348(2):359\u201366. https:\/\/doi.org\/10.1016\/j.bbrc.2006.07.090.","journal-title":"Biochem Biophys Res Commun"},{"key":"274_CR29","doi-asserted-by":"publisher","unstructured":"Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M. Cannabidiol for neurodegenerative disorders: a comprehensive review. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.989717.","DOI":"10.3389\/fphar.2022.989717"},{"issue":"8","key":"274_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tips.2007.06.011","volume":"28","author":"JG Baker","year":"2007","unstructured":"Baker JG, Hill SJ. Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci. 2007;28(8):374\u201381. https:\/\/doi.org\/10.1016\/j.tips.2007.06.011.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"274_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","volume":"53","author":"L Bertilsson","year":"2002","unstructured":"Bertilsson L, Dahl ML, Dal\u00e9n P, Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol. 2002;53(2):111\u201322. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.01548.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"274_CR32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","volume":"156","author":"DA Brown","year":"2009","unstructured":"Brown DA, Passmore GM. Neural KCNQ (Kv7) channels. Br J Pharmacol. 2009;156(8):1185\u201395. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00111.x.","journal-title":"Br J Pharmacol"},{"issue":"22","key":"274_CR33","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/ajhp\/zxaa268","volume":"77","author":"J Cortopassi","year":"2020","unstructured":"Cortopassi J. Warfarin dose adjustment required after cannabidiol initiation and titration. Am J Health Syst Pharm. 2020;77(22):1846\u201351. https:\/\/doi.org\/10.1093\/ajhp\/zxaa268.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"274_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","volume":"143","author":"B Costa","year":"2004","unstructured":"B Costa, G Giagnoni, C Franke, AE Trovato, M Colleoni. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation Br J Pharmacol. 2004;143(2):247-250 https:\/\/doi.org\/10.1038\/sj.bjp.0705920","journal-title":"Br J Pharmacol"},{"key":"274_CR35","unstructured":"D Chormanski MR Muzio. 17-Hydroxylase Deficiency. In: StatPearls StatPearls Publishing 2023 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546644\/. Accessed 18 Oct 2023"},{"issue":"1","key":"274_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/00325481.2019.1685298","volume":"132","author":"A Capano","year":"2020","unstructured":"Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020;132(1):56\u201361. https:\/\/doi.org\/10.1080\/00325481.2019.1685298.","journal-title":"Postgrad Med"},{"issue":"1","key":"274_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/can.2018.0006","volume":"3","author":"J Corroon","year":"2018","unstructured":"Corroon J, Phillips JA. A Cross-Sectional Study of Cannabidiol Users. Cannabis and Cannabinoid Research. 2018;3(1):152\u201361. https:\/\/doi.org\/10.1089\/can.2018.0006.","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"11","key":"274_CR38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","volume":"28","author":"MHN Chagas","year":"2014","unstructured":"Chagas MHN, Zuardi AW, Tumas V, et al. Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: An exploratory double-blind trial. J Psychopharmacol. 2014;28(11):1088\u201398. https:\/\/doi.org\/10.1177\/0269881114550355.","journal-title":"J Psychopharmacol"},{"issue":"7","key":"274_CR39","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.3390\/molecules28073271","volume":"28","author":"J Castillo-Arellano","year":"2023","unstructured":"Castillo-Arellano J, Canseco-Alba A, Cutler SJ, Le\u00f3n F. The Polypharmacological Effects of Cannabidiol. Molecules. 2023;28(7):3271. https:\/\/doi.org\/10.3390\/molecules28073271.","journal-title":"Molecules"},{"issue":"10","key":"274_CR40","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/nu14102101","volume":"14","author":"RB Child","year":"2022","unstructured":"Child RB, Tallon MJ. Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue. Nutrients. 2022;14(10):2101. https:\/\/doi.org\/10.3390\/nu14102101.","journal-title":"Nutrients"},{"issue":"8","key":"274_CR41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.bbadis.2007.03.003","volume":"1772","author":"DN Cortright","year":"2007","unstructured":"Cortright DN, Krause JE, Broom DC. TRP channels and pain. Biochim Biophys Acta (BBA) Mol Basis Dis. 2007;1772(8):978\u201388. https:\/\/doi.org\/10.1016\/j.bbadis.2007.03.003.","journal-title":"Biochim Biophys Acta (BBA). Mol Basis Dis"},{"issue":"4","key":"274_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/jre.13118","volume":"58","author":"H Chen","year":"2023","unstructured":"Chen H, Liu Y, Yu S, Li C, Gao B, Zhou X. Cannabidiol attenuates periodontal inflammation through inhibiting TLR4\/NF-\u03baB pathway. J Periodontal Res. 2023;58(4):697\u2013707. https:\/\/doi.org\/10.1111\/jre.13118.","journal-title":"J Periodontal Res"},{"issue":"1","key":"274_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases. Microbiol Mol Biol Rev. 2011;75(1):50\u201383. https:\/\/doi.org\/10.1128\/MMBR.00031-10.","journal-title":"Microbiol Mol Biol Rev"},{"key":"274_CR44","unstructured":"CYP3A7 Gene - Cytochrome P450 Family 3 Subfamily A Member 7 (n.d.).\u00a0https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=CYP3A7&keywords=cyp3a7."},{"key":"274_CR45","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2689027\/v1","author":"C Caldari-Torres","year":"2023","unstructured":"C Caldari-Torres M Huang D Kasprovic Y Xu 2023 Cannabidiol treatment of proliferating 3T3-L1 pre-adipocytes affects mature cell size and expression of acyltransferases involved in lipid droplet synthesi Published online https:\/\/doi.org\/10.21203\/rs.3.rs-2689027\/v1","journal-title":"Published online"},{"issue":"1","key":"274_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/cells10010092","volume":"10","author":"JW Chiu","year":"2021","unstructured":"Chiu JW, Binte Hanafi Z, Chew LCY, Mei Y, Liu H. IL-1\u03b1 Processing, Signaling and Its Role in Cancer Progression. Cells. 2021;10(1):92. https:\/\/doi.org\/10.3390\/cells10010092.","journal-title":"Cells"},{"key":"274_CR47","doi-asserted-by":"crossref","unstructured":"R Chesworth, D Cheng, C Staub, T Karl. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model. Front Pharmacol. 2022;13.\u00a0https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.931384. Accessed 4 Sept 2023.","DOI":"10.3389\/fphar.2022.931384"},{"key":"274_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-pharmtox-011112-140232","volume":"54","author":"WA Catterall","year":"2014","unstructured":"Catterall WA. Sodium channels, inherited epilepsy, and antiepileptic drugs. Annu Rev Pharmacol Toxicol. 2014;54:317\u201338. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140232.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"274_CR49","doi-asserted-by":"publisher","first-page":"114910","DOI":"10.1016\/j.bcp.2022.114910","volume":"197","author":"RC Chang","year":"2022","unstructured":"Chang RC, Thangavelu CS, Joloya EM, Kuo A, Li Z, Blumberg B. Cannabidiol promotes adipogenesis of human and mouse mesenchymal stem cells via PPAR\u03b3 by inducing lipogenesis but not lipolysis. Biochem Pharmacol. 2022;197:114910. https:\/\/doi.org\/10.1016\/j.bcp.2022.114910.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"274_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4161\/chan.4.6.14106","volume":"4","author":"SM Cain","year":"2010","unstructured":"Cain SM, Snutch TP. Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin). 2010;4(6):475\u201382. https:\/\/doi.org\/10.4161\/chan.4.6.14106.","journal-title":"Channels (Austin)"},{"issue":"5090","key":"274_CR51","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946\u20139. https:\/\/doi.org\/10.1126\/science.1470919.","journal-title":"Science"},{"issue":"5","key":"274_CR52","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","volume":"34","author":"WA Devane","year":"1988","unstructured":"WA Devane, FA Dysarz, MR Johnson, LS Melvin, AC Howlett. Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 1988;34(5):605-613","journal-title":"Mol Pharmacol"},{"key":"274_CR53","unstructured":"Data and Statistics. April 22 2022 https:\/\/www.cdc.gov\/marijuana\/data-statistics.htm. Accessed 31 Jul 2023"},{"issue":"2","key":"274_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA. Proinflammatory Cytokines. Chest. 2000;118(2):503\u20138. https:\/\/doi.org\/10.1378\/chest.118.2.503.","journal-title":"Chest"},{"issue":"4","key":"274_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1208\/s12248-021-00616-7","volume":"23","author":"PT Doohan","year":"2021","unstructured":"Doohan PT, Oldfield LD, Arnold JC, Anderson LL. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization. AAPS J. 2021;23(4):91. https:\/\/doi.org\/10.1208\/s12248-021-00616-7.","journal-title":"AAPS J."},{"key":"274_CR56","unstructured":"L Dean. Warfarin therapy and VKORC1 and CYP Genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, eds. Medical genetics summaries. National Center for Biotechnology Information (US). 2012.\u00a0http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK84174\/\n. Accessed 22 Jun 2023."},{"issue":"Pt 9","key":"274_CR57","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/brain\/aws225","volume":"135","author":"N Eijkelkamp","year":"2012","unstructured":"Eijkelkamp N, Linley JE, Baker MD, et al. Neurological perspectives on voltage-gated sodium channels. Brain. 2012;135(Pt 9):2585\u2013612. https:\/\/doi.org\/10.1093\/brain\/aws225.","journal-title":"Brain"},{"issue":"13","key":"274_CR58","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1073\/pnas.94.13.7070","volume":"94","author":"MU Ehrengruber","year":"1997","unstructured":"Ehrengruber MU, Doupnik CA, Xu Y, et al. Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons. Proc Natl Acad Sci. 1997;94(13):7070\u20135. https:\/\/doi.org\/10.1073\/pnas.94.13.7070.","journal-title":"Proc Natl Acad Sci"},{"key":"274_CR59","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fncel.2013.00076","volume":"7","author":"M Engel","year":"2013","unstructured":"Engel M, Smidt MP, van Hooft JA. The serotonin 5-HT3 receptor: a novel neurodevelopmental target. Front Cell Neurosci. 2013;7:76. https:\/\/doi.org\/10.3389\/fncel.2013.00076.","journal-title":"Front Cell Neurosci"},{"key":"274_CR60","doi-asserted-by":"publisher","first-page":"1138556","DOI":"10.3389\/fphar.2023.1138556","volume":"14","author":"M Estacion","year":"2023","unstructured":"Estacion M, Liu S, Cheng X, Dib-Hajj S, Waxman SG. Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability. Front Pharmacol. 2023;14:1138556. https:\/\/doi.org\/10.3389\/fphar.2023.1138556.","journal-title":"Front Pharmacol"},{"issue":"2","key":"274_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0269881119895536","volume":"34","author":"SM de Faria","year":"2020","unstructured":"de Faria SM, de Morais FD, Tumas V, et al. Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson\u2019s disease. J Psychopharmacol. 2020;34(2):189\u201396. https:\/\/doi.org\/10.1177\/0269881119895536.","journal-title":"J Psychopharmacol"},{"issue":"9","key":"274_CR62","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1523\/JNEUROSCI.10-09-02950.1990","volume":"10","author":"RD Fields","year":"1990","unstructured":"Fields RD, Neale EA, Nelson PG. Effects of patterned electrical activity on neurite outgrowth from mouse sensory neurons. J Neurosci. 1990;10(9):2950\u201364. https:\/\/doi.org\/10.1523\/JNEUROSCI.10-09-02950.1990.","journal-title":"J Neurosci"},{"issue":"12","key":"274_CR63","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s40262-020-00931-w","volume":"59","author":"V Franco","year":"2020","unstructured":"Franco V, Gershkovich P, Perucca E, Bialer M. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations. Clin Pharmacokinet. 2020;59(12):1493\u2013500. https:\/\/doi.org\/10.1007\/s40262-020-00931-w.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"274_CR64","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0006-3495(03)75033-4","volume":"84","author":"TM Frimurer","year":"2003","unstructured":"Frimurer TM, Peters GH, Iversen LF, Andersen HS, M\u00f8ller NPH, Olsen OH. Ligand-Induced Conformational Changes: Improved Predictions of Ligand Binding Conformations and Affinities. Biophys J. 2003;84(4):2273\u201381.","journal-title":"Biophys J"},{"key":"274_CR65","unstructured":"Full article: Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12 n.d https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03602532.2018.1428616. Accessed 21 Jun 2023"},{"issue":"16","key":"274_CR66","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1073\/pnas.90.16.7656","volume":"90","author":"CC Felder","year":"1993","unstructured":"Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K. WA Devane. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction Proc Natl Acad Sci U S A. 1993;90(16):7656\u201360. https:\/\/doi.org\/10.1073\/pnas.90.16.7656.","journal-title":"Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction Proc Natl Acad Sci U S A"},{"issue":"43","key":"274_CR67","doi-asserted-by":"publisher","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","volume":"293","author":"MR Ghovanloo","year":"2018","unstructured":"Ghovanloo MR, Shuart NG, Mezeyova J, Dean RA, Ruben PC, Goodchild SJ. Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem. 2018;293(43):16546\u201358. https:\/\/doi.org\/10.1074\/jbc.RA118.004929.","journal-title":"J Biol Chem"},{"key":"274_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ebcr.2017.10.001","volume":"9","author":"L Grayson","year":"2017","unstructured":"Grayson L, Vines B, Nichol K, Szaflarski JP. An interaction between warfarin and cannabidiol, a case report. Epilepsy Behav Case Rep. 2017;9:10\u20131. https:\/\/doi.org\/10.1016\/j.ebcr.2017.10.001.","journal-title":"Epilepsy Behav Case Rep"},{"issue":"1","key":"274_CR69","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1021\/acsomega.8b03481","volume":"4","author":"E Gilberg","year":"2019","unstructured":"Gilberg E, G\u00fctschow M, Bajorath J. Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots. ACS Omega. 2019;4(1):1729\u201337. https:\/\/doi.org\/10.1021\/acsomega.8b03481.","journal-title":"ACS Omega"},{"key":"274_CR70","unstructured":"GPR55 protein expression summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000135898-GPR55. Accessed 19 Jul 2023"},{"issue":"4","key":"274_CR71","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/10738584211017009","volume":"28","author":"MR Ghovanloo","year":"2022","unstructured":"Ghovanloo MR, Ruben PC. Cannabidiol and sodium channel pharmacology: general overview, mechanism, and clinical implications. Neuroscientist. 2022;28(4):318\u201334. https:\/\/doi.org\/10.1177\/10738584211017009.","journal-title":"Neuroscientist."},{"issue":"1","key":"274_CR72","doi-asserted-by":"publisher","first-page":"14953","DOI":"10.1038\/srep14953","volume":"5","author":"G Godlewski","year":"2015","unstructured":"Godlewski G, Jourdan T, Szanda G, et al. Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue. Sci Rep. 2015;5(1):14953. https:\/\/doi.org\/10.1038\/srep14953.","journal-title":"Sci Rep"},{"key":"274_CR73","doi-asserted-by":"publisher","unstructured":"S Goodman, E Wadsworth, G Schauer, D Hammond. Use and Perceptions of Cannabidiol Products in Canada and in the United States Cannabis and Cannabinoid Research. 2022;7(3):355-364 https:\/\/doi.org\/10.1089\/can.2020.0093","DOI":"10.1089\/can.2020.0093"},{"issue":"1","key":"274_CR74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drudis.2008.11.005","volume":"14","author":"MJ Gunthorpe","year":"2009","unstructured":"Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today. 2009;14(1):56\u201367. https:\/\/doi.org\/10.1016\/j.drudis.2008.11.005.","journal-title":"Drug Discov Today."},{"issue":"12","key":"274_CR75","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.3390\/ijms20122906","volume":"20","author":"S Giorgi","year":"2019","unstructured":"Giorgi S, Nikolaeva-Koleva M, Alarc\u00f3n-Alarc\u00f3n D, Butr\u00f3n L, Gonz\u00e1lez-Rodr\u00edguez S. Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain? Int J Mol Sci. 2019;20(12):2906. https:\/\/doi.org\/10.3390\/ijms20122906.","journal-title":"Int J Mol Sci"},{"key":"274_CR76","unstructured":"GPR12 protein expression summary - The Human Protein Atlas n.d. https:\/\/www.proteinatlas.org\/ENSG00000132975-GPR12. Accessed 19 Jul 2023"},{"issue":"10","key":"274_CR77","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/cells9102207","volume":"9","author":"V Gadiyar","year":"2020","unstructured":"Gadiyar V, Lahey KC, Calianese D, et al. Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy. Cells. 2020;9(10):2207. https:\/\/doi.org\/10.3390\/cells9102207.","journal-title":"Cells"},{"key":"274_CR78","doi-asserted-by":"publisher","unstructured":"Gees M, Colsoul B, Nilius B. The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol. 2010;2(10). https:\/\/doi.org\/10.1101\/cshperspect.a003962.","DOI":"10.1101\/cshperspect.a003962"},{"key":"274_CR79","unstructured":"MH Grider R Jessu R Kabir. Physiology, Action Potential. In: StatPearls. StatPearls Publishing 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538143\/. Accessed 23 Oct 2023"},{"issue":"1","key":"274_CR80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/039463201002300103","volume":"23","author":"ES Graham","year":"2010","unstructured":"Graham ES, Angel CE, Schwarcz LE, Dunbar PR, Glass M. Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry. Int J Immunopathol Pharmacol. 2010;23(1):25\u201334. https:\/\/doi.org\/10.1177\/039463201002300103.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"274_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1476-5381.1989.tb11948.x","volume":"97","author":"GA Higgins","year":"1989","unstructured":"Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol. 1989;97(1):247\u201355.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"274_CR82","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA. Human Cannabinoid Pharmacokinetics. Chem Biodivers. 2007;4(8):1770\u2013804. https:\/\/doi.org\/10.1002\/cbdv.200790152.","journal-title":"Chem Biodivers"},{"issue":"5","key":"274_CR83","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1189\/jlb.72.5.847","volume":"72","author":"E Hoffmann","year":"2002","unstructured":"Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72(5):847\u201355.","journal-title":"J Leukoc Biol"},{"issue":"40","key":"274_CR84","doi-asserted-by":"publisher","first-page":"e2204828119","DOI":"10.1073\/pnas.2204828119","volume":"119","author":"Y Huang","year":"2022","unstructured":"Huang Y, Rafael Guimar\u00e3es T, Todd N, et al. G protein\u2013biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2022;119(40):e2204828119. https:\/\/doi.org\/10.1073\/pnas.2204828119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"274_CR85","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/0897190019854958","volume":"33","author":"A Hsu","year":"2020","unstructured":"A Hsu, NA Painter. Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis. J Pharm Pract. 2020;33(6):915-918 https:\/\/doi.org\/10.1177\/0897190019854958.","journal-title":"J Pharm Pract"},{"issue":"2","key":"274_CR86","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ydbio.2005.08.019","volume":"287","author":"M Hinckley","year":"2005","unstructured":"Hinckley M, Vaccari S, Horner K, Chen R, Conti M. The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. Dev Biol. 2005;287(2):249\u201361. https:\/\/doi.org\/10.1016\/j.ydbio.2005.08.019.","journal-title":"Dev Biol"},{"issue":"3","key":"274_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/can.2020.0105","volume":"6","author":"FR Henshaw","year":"2021","unstructured":"Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. Cannabis and Cannabinoid Research. 2021;6(3):177\u201395. https:\/\/doi.org\/10.1089\/can.2020.0105.","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"7","key":"274_CR88","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1073\/pnas.061029898","volume":"98","author":"L Hanu\u0161","year":"2001","unstructured":"Hanu\u0161 L, Abu-Lafi S, Fride E, et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A. 2001;98(7):3662\u20135. https:\/\/doi.org\/10.1073\/pnas.061029898.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"274_CR89","doi-asserted-by":"publisher","first-page":"118624","DOI":"10.1016\/j.lfs.2020.118624","volume":"264","author":"F Hao","year":"2021","unstructured":"Hao F, Feng Y. Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP\/PS1 Alzheimer\u2019s mice uncovered by RNA-seq. Life Sci. 2021;264:118624. https:\/\/doi.org\/10.1016\/j.lfs.2020.118624.","journal-title":"Life Sci"},{"issue":"9","key":"274_CR90","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0898-6568(98)00013-8","volume":"10","author":"DB Houston","year":"1998","unstructured":"Houston DB, Howlett AC. Differential receptor\u2013G-protein coupling evoked by dissimilar cannabinoid receptor agonists. Cell Signal. 1998;10(9):667\u201374. https:\/\/doi.org\/10.1016\/S0898-6568(98)00013-8.","journal-title":"Cell Signal"},{"key":"274_CR91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41398-023-02410-9","volume":"13","author":"DYH Hua","year":"2023","unstructured":"Hua DYH, Hindocha C, Baio G. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Transl Psychiatry. 2023;13:131. https:\/\/doi.org\/10.1038\/s41398-023-02410-9.","journal-title":"Transl Psychiatry"},{"key":"274_CR92","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cbi.2017.06.005","volume":"273","author":"YS Hwang","year":"2017","unstructured":"Hwang YS, Kim YJ, Kim MO, et al. Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42\/44 MAPK. Chem Biol Interact. 2017;273:107\u201314. https:\/\/doi.org\/10.1016\/j.cbi.2017.06.005.","journal-title":"Chem Biol Interact"},{"key":"274_CR93","unstructured":"HTR3A protein expression summary - The Human Protein Atlas.n.d https:\/\/www.proteinatlas.org\/ENSG00000166736-HTR3A Accessed 19 Jul 2023"},{"key":"274_CR94","doi-asserted-by":"publisher","first-page":"821758","DOI":"10.3389\/fphar.2022.821758","volume":"13","author":"D Isaev","year":"2022","unstructured":"Isaev D, Shabbir W, Dinc EY, Lorke DE, Petroianu G, Oz M. Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes Front Pharmacol. 2022;13:821758. https:\/\/doi.org\/10.3389\/fphar.2022.821758.","journal-title":"Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes Front Pharmacol"},{"issue":"5","key":"274_CR95","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.bpj.2014.11.3489","volume":"108","author":"R Iosub","year":"2015","unstructured":"Iosub R, Avitabile D, Grant L, Tsaneva-Atanasova K, Kennedy HJ. Calcium-induced calcium release during action potential firing in developing inner hair cells. Biophys J. 2015;108(5):1003\u201312. https:\/\/doi.org\/10.1016\/j.bpj.2014.11.3489.","journal-title":"Biophys J"},{"key":"274_CR96","unstructured":"Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs - Full Text View - ClinicalTrials.gov n.d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04201197. Accessed 21 Jun 2023"},{"issue":"6662","key":"274_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/34184","volume":"391","author":"C Jiang","year":"1998","unstructured":"Jiang C, Ting AT, Seed B. PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391(6662):82\u20136. https:\/\/doi.org\/10.1038\/34184.","journal-title":"Nature"},{"issue":"1","key":"274_CR98","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","volume":"207","author":"M Jenny","year":"2009","unstructured":"Jenny M, Santer E, Pirich E, Schennach H, Fuchs D. \u03949-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro. J Neuroimmunol. 2009;207(1):75\u201382. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.004.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"274_CR99","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3390\/ph3082647","volume":"3","author":"M Jenny","year":"2010","unstructured":"Jenny M, Schr\u00f6cksnadel S, \u00dcberall F, Fuchs D. The potential role of cannabinoids in modulating serotonergic signaling by their influence on tryptophan metabolism. Pharmaceuticals (Basel). 2010;3(8):2647\u201360. https:\/\/doi.org\/10.3390\/ph3082647.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"274_CR100","doi-asserted-by":"publisher","first-page":"e0145269","DOI":"10.1371\/journal.pone.0145269","volume":"10","author":"KI Jang","year":"2015","unstructured":"Jang KI, Lee SH, Huh HJ, Chae JH. Influence of the 5-HT3A Receptor Gene Polymorphism and Childhood Sexual Trauma on Central Serotonin Activity. PLoS One. 2015;10(12):e0145269. https:\/\/doi.org\/10.1371\/journal.pone.0145269.","journal-title":"PLoS One"},{"issue":"3","key":"274_CR101","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0165-6147(96)10002-X","volume":"17","author":"KA Jacobson","year":"1996","unstructured":"Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci. 1996;17(3):108\u201313.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"274_CR102","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2133\/dmpk.DMPK-12-RG-129","volume":"28","author":"R Jiang","year":"2013","unstructured":"Jiang R, Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug Metab Pharmacokinet. 2013;28(4):332\u20138. https:\/\/doi.org\/10.2133\/dmpk.DMPK-12-RG-129.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"274_CR103","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/antiox12020485","volume":"12","author":"G J\u00eetc\u0103","year":"2023","unstructured":"J\u00eetc\u0103 G, \u0150sz BE, Vari CE, Rusz CM, Tero-Vescan A, Pu\u0219ca\u0219 A. Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants (Basel). 2023;12(2):485. https:\/\/doi.org\/10.3390\/antiox12020485.","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"274_CR104","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0828-282X(09)70117-5","volume":"25","author":"DI Keller","year":"2009","unstructured":"DI Keller J Grenier G Christ\u00e9 2009 Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures Can J Cardiol 25(8):455-462 https:\/\/doi.org\/10.1016\/S0828-282X(09)70117-5","journal-title":"Can J Cardiol"},{"issue":"5","key":"274_CR105","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","volume":"372","author":"M Kathmann","year":"2006","unstructured":"Kathmann M, Flau K, Redmer A, Tr\u00e4nkle C, Schlicker E. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmied Arch Pharmacol. 2006;372(5):354\u201361. https:\/\/doi.org\/10.1007\/s00210-006-0033-x.","journal-title":"Naunyn Schmied Arch Pharmacol"},{"issue":"5","key":"274_CR106","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1152\/jn.00128.2020","volume":"124","author":"CW Kowalski","year":"2020","unstructured":"Kowalski CW, Ragozzino FJ, Lindberg JEM. Cannabidiol activation of vagal afferent neurons requires TRPA1. J Neurophysiol. 2020;124(5):1388\u201398. https:\/\/doi.org\/10.1152\/jn.00128.2020.","journal-title":"J Neurophysiol."},{"issue":"2","key":"274_CR107","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/FBP.0000000000000023","volume":"25","author":"AJ Kwilasz","year":"2014","unstructured":"Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS. Effects of the Fatty Acid Amide Hydrolase (FAAH) Inhibitor URB597 on Pain-Stimulated and Pain-Depressed Behavior in Rats. Behav Pharmacol. 2014;25(2):119\u201329. https:\/\/doi.org\/10.1097\/FBP.0000000000000023.","journal-title":"Behav Pharmacol"},{"issue":"4","key":"274_CR108","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/cancers14040885","volume":"14","author":"K O\u2019Brien","year":"2022","unstructured":"K O\u2019Brien 2022 Cannabidiol (CBD) in Cancer Management Cancers 14 4 885 https:\/\/doi.org\/10.3390\/cancers14040885","journal-title":"Cancers"},{"issue":"1","key":"274_CR109","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/prot.26215","volume":"90","author":"S Kondra","year":"2022","unstructured":"Kondra S, Chen F, Chen Y, Chen Y, Collette CJ, Xu W. A study of a hierarchical structure of proteins and ligand binding sites of receptors using the triangular spatial relationship-based structure comparison method and development of a size-filtering feature designed for comparing different sizes of protein structures. Proteins Struct Function Bioinformatics. 2022;90(1):239\u201357. https:\/\/doi.org\/10.1002\/prot.26215.","journal-title":"Proteins Struct Function Bioinformatics."},{"issue":"3","key":"274_CR110","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","volume":"2","author":"FM Leweke","year":"2012","unstructured":"Leweke FM, Piomelli D, Pahlisch F, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012;2(3):e94. https:\/\/doi.org\/10.1038\/tp.2012.15.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"274_CR111","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","volume":"79","author":"HC Lu","year":"2016","unstructured":"Lu HC, Mackie K. An introduction to the endogenous cannabinoid system. Biol Psychiatry. 2016;79(7):516\u201325. https:\/\/doi.org\/10.1016\/j.biopsych.2015.07.028.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"274_CR112","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","volume":"40","author":"AS Laun","year":"2019","unstructured":"Laun AS, Shrader SH, Brown KJ, Song ZH. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. Acta Pharmacol Sin. 2019;40(3):300\u20138. https:\/\/doi.org\/10.1038\/s41401-018-0031-9.","journal-title":"Acta Pharmacol Sin."},{"key":"274_CR113","doi-asserted-by":"publisher","unstructured":"AS Laun, ZH Song. GPR3 and GPR6, novel molecular targets for cannabidiol. Biochem Biophys Res Commun. 2017;490(1);17-21.\u00a0https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.165.","DOI":"10.1016\/j.bbrc.2017.05.165"},{"issue":"7","key":"274_CR114","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","volume":"105","author":"JE Lauckner","year":"2008","unstructured":"Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A. 2008;105(7):2699\u2013704. https:\/\/doi.org\/10.1073\/pnas.0711278105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"274_CR115","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.abb.2019.108078","volume":"673","author":"H Li","year":"2019","unstructured":"Li H, Lampe JN. Neonatal cytochrome P450 CYP3A7: a comprehensive review of its role in development, disease, and xenobiotic metabolism. Arch Biochem Biophys. 2019;673:108078. https:\/\/doi.org\/10.1016\/j.abb.2019.108078.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"274_CR116","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/cr.2011.205","volume":"22","author":"Z Luo","year":"2012","unstructured":"Luo Z, Ma L, Zhao Z, et al. TRPV1 activation improves exercise endurance and energy metabolism through PGC-1\u03b1 upregulation in mice. Cell Res. 2012;22(3):551\u201364. https:\/\/doi.org\/10.1038\/cr.2011.205.","journal-title":"Cell Res"},{"issue":"6","key":"274_CR117","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1021\/acs.jnatprod.0c00138","volume":"83","author":"C Liu","year":"2020","unstructured":"Liu C, Ma H, Slitt AL, Seeram NP. Inhibitory Effect of Cannabidiol on the Activation of NLRP3 Inflammasome Is Associated with Its Modulation of the P2X7 Receptor in Human Monocytes. J Nat Prod. 2020;83(6):2025\u20139. https:\/\/doi.org\/10.1021\/acs.jnatprod.0c00138.","journal-title":"J Nat Prod"},{"issue":"11","key":"274_CR118","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/bcp.13710","volume":"84","author":"CJ Lucas","year":"2018","unstructured":"Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018;84(11):2477\u201382. https:\/\/doi.org\/10.1111\/bcp.13710.","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"274_CR119","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly MEM, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790\u2013805. https:\/\/doi.org\/10.1111\/bph.13250.","journal-title":"Br J Pharmacol"},{"key":"274_CR120","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","volume":"178","author":"F Li","year":"2017","unstructured":"Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther. 2017;178:18\u201330. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.03.007.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"274_CR121","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11010-012-1287-x","volume":"366","author":"X Lu","year":"2012","unstructured":"Lu X, Zhang N, Meng B, Dong S, Hu Y. Involvement of GPR12 in the regulation of cell proliferation and survival. Mol Cell Biochem. 2012;366(1):101\u201310. https:\/\/doi.org\/10.1007\/s11010-012-1287-x.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"274_CR122","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","volume":"54","author":"JK Lamba","year":"2002","unstructured":"Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 2002;54(10):1271\u201394. https:\/\/doi.org\/10.1016\/S0169-409X(02)00066-2.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"274_CR123","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1097\/00001756-199808030-00033","volume":"9","author":"M Leone","year":"1998","unstructured":"Leone M, Attanasio A, Croci D, et al. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. NeuroReport. 1998;9(11):2605\u20138. https:\/\/doi.org\/10.1097\/00001756-199808030-00033.","journal-title":"NeuroReport"},{"issue":"5","key":"274_CR124","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1042\/BST20220271","volume":"50","author":"RM Lucas","year":"2022","unstructured":"Lucas RM, Luo L, Stow JL. ERK1\/2 in immune signalling. Biochem Soc Trans. 2022;50(5):1341\u201352. https:\/\/doi.org\/10.1042\/BST20220271.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"274_CR125","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1523\/JNEUROSCI.4423-14.2015","volume":"35","author":"F Miceli","year":"2015","unstructured":"Miceli F, Soldovieri MV, Ambrosino P. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits. J Neurosci. 2015;35(9):3782\u201393. https:\/\/doi.org\/10.1523\/JNEUROSCI.4423-14.2015.","journal-title":"J Neurosci"},{"key":"274_CR126","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3389\/fphar.2020.01276","volume":"11","author":"LFS Menezes","year":"2020","unstructured":"Menezes LFS, Sabi\u00e1 J\u00fanior EF, Tibery DV, Carneiro LD, Schwartz EF. Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review. Front Pharmacol. 2020;11:1276. https:\/\/doi.org\/10.3389\/fphar.2020.01276.","journal-title":"Front Pharmacol."},{"issue":"12","key":"274_CR127","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809\u201323. https:\/\/doi.org\/10.1038\/s41569-021-00569-6.","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"274_CR128","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00018-006-6156-x","volume":"63","author":"P Massi","year":"2006","unstructured":"Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci. 2006;63(17):2057\u201366. https:\/\/doi.org\/10.1007\/s00018-006-6156-x.","journal-title":"Cell Mol Life Sci"},{"key":"274_CR129","doi-asserted-by":"publisher","unstructured":"M Marois Le, V Ballet, C Sanson. Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro. Eur J Pharmacol. 2020;886:173542.\u00a0https:\/\/doi.org\/10.1016\/j.ejphar.2020.173542.","DOI":"10.1016\/j.ejphar.2020.173542"},{"key":"274_CR130","unstructured":"EJ Miller, SL Lappin. Physiology, cellular receptor StatPearls StatPearls Publishing 2023 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554403\/. Accessed 22 Jun 2023"},{"issue":"1","key":"274_CR131","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41598-020-61677-w","volume":"10","author":"G Moraga-Cid","year":"2020","unstructured":"Moraga-Cid G, San Mart\u00edn VP, Lara CO, et al. Modulation of glycine receptor single-channel conductance by intracellular phosphorylation. Sci Rep. 2020;10(1):4804. https:\/\/doi.org\/10.1038\/s41598-020-61677-w.","journal-title":"Sci Rep"},{"issue":"4, Supplement","key":"274_CR132","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1016\/j.jagp.2021.01.107","volume":"29","author":"K McManus","year":"2021","unstructured":"McManus K, Ash E, Harper D, Smith R, Gruber S, Forester B. Caring for Behavioral Symptoms of Dementia (CBD): a new investigation into cannabidiol for the treatment of anxiety and agitation in Alzheimer\u2019s dementia. Am J Geriatr Psychiatry. 2021;29(4, Supplement):S110\u20131. https:\/\/doi.org\/10.1016\/j.jagp.2021.01.107.","journal-title":"Am J Geriatr Psychiatry."},{"key":"274_CR133","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","volume":"59","author":"M Mecha","year":"2013","unstructured":"Mecha M, Feli\u00fa A, I\u00f1igo PM, Mestre L, Carrillo-Salinas FJ, Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors. Neurobiol Dis. 2013;59:141\u201350. https:\/\/doi.org\/10.1016\/j.nbd.2013.06.016.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"274_CR134","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","volume":"104","author":"P Massi","year":"2008","unstructured":"Massi P, Valenti M, Vaccani A, et al. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. J Neurochem. 2008;104(4):1091\u2013100. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05073.x.","journal-title":"J Neurochem"},{"key":"274_CR135","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/JIR.S277457","volume":"13","author":"MD Molla","year":"2020","unstructured":"Molla MD, Akalu Y, Geto Z, Dagnew B, Ayelign B, Shibabaw T. Role of Caspase-1 in the Pathogenesis of Inflammatory-Associated Chronic Noncommunicable Diseases. J Inflamm Res. 2020;13:749\u201364. https:\/\/doi.org\/10.2147\/JIR.S277457.","journal-title":"J Inflamm Res"},{"issue":"8","key":"274_CR136","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","volume":"8","author":"Y Mebratu","year":"2009","unstructured":"Mebratu Y, Tesfaigzi Y. How ERK1\/2 Activation Controls Cell Proliferation and Cell Death Is Subcellular Localization the Answer? Cell Cycle. 2009;8(8):1168\u201375.","journal-title":"Cell Cycle"},{"key":"274_CR137","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.smim.2017.12.006","volume":"36","author":"A Mantovani","year":"2018","unstructured":"Mantovani A. Redundancy and Robustness Versus Division of Labour and Specialization in Innate Immunity. Semin Immunol. 2018;36:28\u201330. https:\/\/doi.org\/10.1016\/j.smim.2017.12.006.","journal-title":"Semin Immunol"},{"key":"274_CR138","doi-asserted-by":"crossref","unstructured":"C Muller P Morales PH Reggio. Cannabinoid Ligands Targeting TRP Channels. Front Mol Neurosci 2019 11 https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2018.00487. Accessed 22 Nov 2022","DOI":"10.3389\/fnmol.2018.00487"},{"key":"274_CR139","unstructured":"Marijuana legality by state - Updated Oct 1, 2023. DISA 2025 https:\/\/disa.com\/marijuana-legality-by-state"},{"issue":"2","key":"274_CR140","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1110\/ps.21302","volume":"11","author":"B Ma","year":"2002","unstructured":"Ma B, Shatsky M, Wolfson HJ, Nussinov R. Multiple diverse ligands binding at a single protein site: A matter of pre-existing populations. Protein Sci. 2002;11(2):184\u201397.","journal-title":"Protein Sci"},{"issue":"4","key":"274_CR141","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/0896-6273(92)90083-P","volume":"8","author":"E Neher","year":"1992","unstructured":"Neher E. Ion channels for communication between and within cells. Neuron. 1992;8(4):605\u201312. https:\/\/doi.org\/10.1016\/0896-6273(92)90083-P.","journal-title":"Neuron"},{"key":"274_CR142","doi-asserted-by":"publisher","unstructured":"Navarro G, Varani K, Lillo A, et al. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors. Pharmacol Res. 2020;159. https:\/\/doi.org\/10.1016\/j.phrs.2020.104940.","DOI":"10.1016\/j.phrs.2020.104940"},{"issue":"21","key":"274_CR143","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","volume":"63","author":"KM Nelson","year":"2020","unstructured":"Nelson KM, Bisson J, Singh G, et al. The Essential Medicinal Chemistry of Cannabidiol (CBD). J Med Chem. 2020;63(21):12137\u201355. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00724.","journal-title":"J Med Chem"},{"key":"274_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2014.04.010","volume":"257","author":"P Oeckl","year":"2014","unstructured":"Oeckl P, Hengerer B, Ferger B. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson\u2019s disease. Exp Neurol. 2014;257:1\u20139. https:\/\/doi.org\/10.1016\/j.expneurol.2014.04.010.","journal-title":"Exp Neurol."},{"issue":"3","key":"274_CR145","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","volume":"172","author":"JM McPartland","year":"2015","unstructured":"McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol. 2015;172(3):737\u201353. https:\/\/doi.org\/10.1111\/bph.12944.","journal-title":"Br J Pharmacol"},{"key":"274_CR146","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","volume":"71","author":"MR Pazos","year":"2013","unstructured":"MR Pazos, N Mohammed, H Lafuente. Mechanisms of cannabidiol neuroprotection in hypoxic\u2013ischemic newborn pigs: Role of 5HT1A and CB2 receptors Neuropharmacology. 2013;71:282-291 https:\/\/doi.org\/10.1016\/j.neuropharm.2013.03.027","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"274_CR147","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2011.01.013","volume":"655","author":"P Pandolfo","year":"2011","unstructured":"Pandolfo P, Silveirinha V, dos Santos-Rodrigues A, et al. Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. Eur J Pharmacol. 2011;655(1\u20133):38\u201345. https:\/\/doi.org\/10.1016\/j.ejphar.2011.01.013.","journal-title":"Eur J Pharmacol"},{"issue":"(3)","key":"274_CR148","doi-asserted-by":"publisher","first-page":"NS20200080","DOI":"10.1042\/NS20200080","volume":"5","author":"SR Pereira","year":"2021","unstructured":"Pereira SR, Hackett B, O\u2019Driscoll DN, Sun MC, Downer EJ. Cannabidiol modulation of oxidative stress and signalling. Neuronal Signal. 2021;5((3)):NS20200080. https:\/\/doi.org\/10.1042\/NS20200080.","journal-title":"Neuronal Signal"},{"issue":"3","key":"274_CR149","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","volume":"301","author":"AC Porter","year":"2002","unstructured":"Porter AC, Sauer JM, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther. 2002;301(3):1020\u20134. https:\/\/doi.org\/10.1124\/jpet.301.3.1020.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"274_CR150","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","journal-title":"Br J Pharmacol"},{"key":"274_CR151","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2016.02.024","volume":"775","author":"MK Park","year":"2016","unstructured":"Park MK, Park S, Kim HJ, et al. Novel effects of FTY720 on perinuclear reorganization of keratin network induced by sphingosylphosphorylcholine: Involvement of protein phosphatase 2A and G-protein-coupled receptor-12. Eur J Pharmacol. 2016;775:86\u201395. https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.024.","journal-title":"Eur J Pharmacol"},{"key":"274_CR152","unstructured":"PPAR\u03b4 regulates glucose metabolism and insulin sensitivity | PNAS n.d https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.0511253103. Accessed 22 Jun 2023"},{"issue":"7","key":"274_CR153","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163(7):1479\u201394. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01166.x.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"274_CR154","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1523\/JNEUROSCI.11-11-03594.1991","volume":"11","author":"NJ Penington","year":"1991","unstructured":"Penington NJ, Kelly JS, Fox AP. A study of the mechanism of Ca2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J Neurosci. 1991;11(11):3594\u2013609. https:\/\/doi.org\/10.1523\/JNEUROSCI.11-11-03594.1991.","journal-title":"J Neurosci"},{"key":"274_CR155","doi-asserted-by":"publisher","unstructured":"L Petrocellis, De V Vellani, A Schiano-Moriello. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther. 2008;325(3):1007-1015.\u00a0https:\/\/doi.org\/10.1124\/jpet.107.134809.","DOI":"10.1124\/jpet.107.134809"},{"issue":"6","key":"274_CR156","doi-asserted-by":"publisher","first-page":"571","DOI":"10.20524\/aog.2020.0528","volume":"33","author":"A Perisetti","year":"2020","unstructured":"Perisetti A, Gajendran M, Dasari CS, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Ann Gastroenterol. 2020;33(6):571\u20138. https:\/\/doi.org\/10.20524\/aog.2020.0528.","journal-title":"Ann Gastroenterol"},{"key":"274_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6123(08)81001-1","volume":"181","author":"BI Posner","year":"2010","unstructured":"Posner BI, Laporte SA. Chapter 1 - Cellular Signalling: Peptide Hormones and Growth Factors. In: Martini L, ed. Progress in Brain Research. Neuroendocrinology: The Normal Neuroendocrine System. Elsevier. 2010;181:1\u201316. https:\/\/doi.org\/10.1016\/S0079-6123(08)81001-1.","journal-title":"Elsevier"},{"key":"274_CR158","doi-asserted-by":"crossref","unstructured":"M Patrick, J Schulenberg, R Miech, L Johnson, P O\u2019Malley, J Bachman. Monitoring the future panel study annual report: national data on substance use among adults ages 19 to 60, (1976\u20132021). 2022 https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2022\/09\/mtfpanelreport2022.pdf","DOI":"10.7826\/ISR-UM.06.585140.002.07.0001.2022"},{"issue":"2","key":"274_CR159","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","volume":"204","author":"L De Petrocellis","year":"2012","unstructured":"De Petrocellis L, Orlando P, Moriello AS, et al. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf). 2012;204(2):255\u201366. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02338.x.","journal-title":"Acta Physiol (Oxf)"},{"issue":"5","key":"274_CR160","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/JCP.0000000000001089","volume":"39","author":"Y Qian","year":"2019","unstructured":"Qian Y, Gurley BJ, Markowitz JS. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications. J Clin Psychopharmacol. 2019;39(5):462\u201371. https:\/\/doi.org\/10.1097\/JCP.0000000000001089.","journal-title":"J Clin Psychopharmacol."},{"issue":"24","key":"274_CR161","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","volume":"28","author":"N Qin","year":"2008","unstructured":"Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons. J Neurosci. 2008;28(24):6231\u20138. https:\/\/doi.org\/10.1523\/JNEUROSCI.0504-08.2008.","journal-title":"J Neurosci."},{"issue":"1\u20132","key":"274_CR162","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuropharm.2011.02.014","volume":"61","author":"J Ruiz-Medina","year":"2011","unstructured":"Ruiz-Medina J, Ledent C, Valverde O. GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception. Neuropharmacology. 2011;61(1\u20132):43\u201350. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.014.","journal-title":"Neuropharmacology"},{"key":"274_CR163","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42238-021-00078-w","volume":"3","author":"L Rapin","year":"2021","unstructured":"Rapin L, Gamaoun R, El Hage C, Arboleda MF, Prosk E. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic. J Cannabis Res. 2021;3:19. https:\/\/doi.org\/10.1186\/s42238-021-00078-w.","journal-title":"J Cannabis Res"},{"issue":"23","key":"274_CR164","doi-asserted-by":"publisher","first-page":"16124","DOI":"10.1074\/jbc.M707104200","volume":"283","author":"HR Ross","year":"2008","unstructured":"Ross HR, Napier I, Connor M. Inhibition of Recombinant Human T-type Calcium Channels by\u00a0\u03949-Tetrahydrocannabinol and Cannabidiol. J Biol Chem. 2008;283(23):16124\u201334. https:\/\/doi.org\/10.1074\/jbc.M707104200.","journal-title":"J Biol Chem"},{"issue":"8","key":"274_CR165","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","volume":"165","author":"E Rock","year":"2012","unstructured":"Rock E, Bolognini D, Limebeer C, et al. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol. 2012;165(8):2620\u201334. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01621.x.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"274_CR166","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/03602532.2018.1483401","volume":"50","author":"S Rendic","year":"2018","unstructured":"Rendic S, Guengerich FP. Human cytochrome P450 enzymes 5\u201351 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition\u2014toxic effects and benefits. Drug Metab Rev. 2018;50(3):256\u2013342. https:\/\/doi.org\/10.1080\/03602532.2018.1483401.","journal-title":"Drug Metab Rev"},{"key":"274_CR167","unstructured":"Results from the 2019 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States | SAMHSA Publications and Digital Products n.d. https:\/\/store.samhsa.gov\/product\/key-substance-use-and-mental-health-indicators-in-the-united-states-results-from-the-2019-national-survey-on-Drug-Use-and-Health\/PEP20-07-01-001 Accessed 30 Oct 2023"},{"issue":"8","key":"274_CR168","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.neuron.2023.01.018","volume":"111","author":"EC Rosenberg","year":"2023","unstructured":"Rosenberg EC, Chamberland S, Bazelot M, et al. Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. Neuron. 2023;111(8):1282-1300.e8. https:\/\/doi.org\/10.1016\/j.neuron.2023.01.018.","journal-title":"Neuron"},{"issue":"8","key":"274_CR169","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.bpj.2020.08.029","volume":"119","author":"N Rodriguez Araujo","year":"2020","unstructured":"Rodriguez Araujo N, Fabiani C, Mazzarini Dimarco A, Bouzat C, Corradi J. Orthosteric and Allosteric Activation of Human 5-HT3A Receptors. Biophys J. 2020;119(8):1670\u201382. https:\/\/doi.org\/10.1016\/j.bpj.2020.08.029.","journal-title":"Biophys J"},{"issue":"14","key":"274_CR170","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2174\/092986710790980005","volume":"17","author":"PH Reggio","year":"2010","unstructured":"Reggio PH. Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown. Curr Med Chem. 2010;17(14):1468\u201386.","journal-title":"Curr Med Chem"},{"issue":"5","key":"274_CR171","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cell.2014.03.051","volume":"157","author":"CE Riera","year":"2014","unstructured":"Riera CE, Huising MO, Follett P, et al. TRPV1 Pain Receptors Regulate Longevity and Metabolism by Neuropeptide Signaling. Cell. 2014;157(5):1023\u201336. https:\/\/doi.org\/10.1016\/j.cell.2014.03.051.","journal-title":"Cell"},{"issue":"2","key":"274_CR172","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.yexcr.2018.07.030","volume":"370","author":"T Ruhl","year":"2018","unstructured":"Ruhl T, Kim BS, Beier JP. Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells. Exp Cell Res. 2018;370(2):653\u201362. https:\/\/doi.org\/10.1016\/j.yexcr.2018.07.030.","journal-title":"Exp Cell Res"},{"issue":"10","key":"274_CR173","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.1038\/tp.2016.195","volume":"6","author":"P Seeman","year":"2016","unstructured":"Seeman P. Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. Transl Psychiatry. 2016;6(10):e920. https:\/\/doi.org\/10.1038\/tp.2016.195.","journal-title":"Transl Psychiatry."},{"key":"274_CR174","doi-asserted-by":"publisher","first-page":"1055481","DOI":"10.3389\/fpsyt.2022.1055481","volume":"13","author":"RT Smith","year":"2023","unstructured":"Smith RT, Gruber SA. Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Front Psychiatry. 2023;13:1055481. https:\/\/doi.org\/10.3389\/fpsyt.2022.1055481.","journal-title":"Front Psychiatry."},{"key":"274_CR175","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","volume":"87","author":"A Samanta","year":"2018","unstructured":"A Samanta TET Hughes VY Moiseenkova-Bell 2018 Transient Receptor Potential (TRP) Channels Subcell Biochem 87:141-165 https:\/\/doi.org\/10.1007\/978-981-10-7757-9_6","journal-title":"Subcell Biochem"},{"issue":"1","key":"274_CR176","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1213\/ANE.0000000000006584","volume":"138","author":"A Sideris","year":"2024","unstructured":"Sideris A, Doan LV. An Overview of Cannabidiol. Anesth Analg. 2024;138(1):54\u201368. https:\/\/doi.org\/10.1213\/ANE.0000000000006584.","journal-title":"Anesth Analg"},{"issue":"12","key":"274_CR177","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","volume":"173","author":"SE O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan SE. An update on PPAR activation by cannabinoids. Br J Pharmacol. 2016;173(12):1899\u2013910. https:\/\/doi.org\/10.1111\/bph.13497.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"274_CR178","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","volume":"612","author":"SE O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan SE, Sun Y, Bennett AJ, Randall MD, Kendall DA. Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol. 2009;612(1):61\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2009.03.010.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"274_CR179","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0014-2999(86)90782-X","volume":"128","author":"JS Sprouse","year":"1986","unstructured":"Sprouse JS, Aghajanian GK. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol. 1986;128(3):295\u20138. https:\/\/doi.org\/10.1016\/0014-2999(86)90782-X.","journal-title":"Eur J Pharmacol"},{"key":"274_CR180","doi-asserted-by":"publisher","unstructured":"KS Swenson LE Gomez Wulschner VM Hoelscher, . Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, problem-solving, and prefrontal cortex excitability. Mol Psychiatry 2023:1-17 https:\/\/doi.org\/10.1038\/s41380-023-02130-y. Published online July 11","DOI":"10.1038\/s41380-023-02130-y"},{"key":"274_CR181","doi-asserted-by":"publisher","unstructured":"KA Sharkey. 11 - Proposed mechanisms of cannabinoid hyperemesis syndrome\u2014how can cannabinoid pathways both relieve and cause vomiting? In: Hasler WL, Levinthal DJ, Venkatesan T, eds. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis. Academic Press 2022 175-200. https:\/\/doi.org\/10.1016\/B978-0-12-821597-5.00003-4","DOI":"10.1016\/B978-0-12-821597-5.00003-4"},{"issue":"2","key":"274_CR182","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-2044.2005.04462.x","volume":"61","author":"BP Sweeney","year":"2006","unstructured":"Sweeney BP, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia. 2006;61(2):159\u201377. https:\/\/doi.org\/10.1111\/j.1365-2044.2005.04462.x.","journal-title":"Anaesthesia"},{"issue":"8","key":"274_CR183","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/dmd.117.078964","volume":"46","author":"M Solanki","year":"2018","unstructured":"Solanki M, Pointon A, Jones B, Herbert K. Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity. Drug Metab Dispos. 2018;46(8):1053\u201365. https:\/\/doi.org\/10.1124\/dmd.117.078964.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"274_CR184","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/mol.55.1.8","volume":"55","author":"M Shen","year":"1999","unstructured":"Shen M, Thayer SA. \u03949-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture Mol Pharmacol. 1999;55(1):8\u201313. https:\/\/doi.org\/10.1124\/mol.55.1.8.","journal-title":"\u03949-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture Mol Pharmacol."},{"issue":"3","key":"274_CR185","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40429-020-00326-8","volume":"7","author":"DJ Sholler","year":"2020","unstructured":"Sholler DJ, Schoene L, Spindle TR. Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies. Curr Addict Rep. 2020;7(3):405\u201312. https:\/\/doi.org\/10.1007\/s40429-020-00326-8.","journal-title":"Curr Addict Rep"},{"issue":"9","key":"274_CR186","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/cells11091391","volume":"11","author":"SV Suryavanshi","year":"2022","unstructured":"Suryavanshi SV, Zaiachuk M, Pryimak N, Kovalchuk I, Kovalchuk O. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro. Cells. 2022;11(9):1391. https:\/\/doi.org\/10.3390\/cells11091391.","journal-title":"Cells"},{"issue":"1","key":"274_CR187","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12881-015-0200-3","volume":"16","author":"K Smets","year":"2015","unstructured":"Smets K, Duarri A, Deconinck T. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy. BMC Med Gen. 2015;16(1):51. https:\/\/doi.org\/10.1186\/s12881-015-0200-3.","journal-title":"BMC Med Gen."},{"issue":"3","key":"274_CR188","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bph.12439","volume":"171","author":"SJ Ward","year":"2014","unstructured":"Ward SJ, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. Br J Pharmacol. 2014;171(3):636\u201345. https:\/\/doi.org\/10.1111\/bph.12439.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"274_CR189","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","volume":"88","author":"J Savitz","year":"2009","unstructured":"Savitz J, Lucki I, Drevets WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009;88(1):17\u201331. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.01.009.","journal-title":"Prog Neurobiol"},{"issue":"853","key":"274_CR190","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/pgmj.72.853.688","volume":"72","author":"DG Tincello","year":"1996","unstructured":"Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J. 1996;72(853):688\u20139. https:\/\/doi.org\/10.1136\/pgmj.72.853.688.","journal-title":"Postgrad Med J"},{"key":"274_CR191","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2014.04.007","volume":"68","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Miyagi T, Dohi E, et al. Developmental expression of GPR3 in rodent cerebellar granule neurons is associated with cell survival and protects neurons from various apoptotic stimuli. Neurobiol Dis. 2014;68:215\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2014.04.007.","journal-title":"Neurobiol Dis"},{"issue":"14","key":"274_CR192","doi-asserted-by":"publisher","first-page":"10506","DOI":"10.1074\/jbc.M700911200","volume":"282","author":"S Tanaka","year":"2007","unstructured":"Tanaka S, Ishii K, Kasai K, Yoon SO, Saeki Y. Neural Expression of G Protein-coupled Receptors GPR3, GPR6, and GPR12 Up-regulates Cyclic AMP Levels and Promotes Neurite Outgrowth *. J Biol Chem. 2007;282(14):10506\u201315. https:\/\/doi.org\/10.1074\/jbc.M700911200.","journal-title":"J Biol Chem"},{"issue":"4","key":"274_CR193","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1476-5381.2012.02043.x","volume":"167","author":"C Tourino","year":"2012","unstructured":"Tourino C, Valjent E, Ruiz-Medina J, Herve D, Ledent C, Valverde O. The orphan receptor GPR3 modulates the early phases of cocaine reinforcement. Br J Pharmacol. 2012;167(4):892\u2013904. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02043.x.","journal-title":"Br J Pharmacol"},{"key":"274_CR194","unstructured":"J Theriot HR Wermuth JV Ashurst. Antiemetic Serotonin-5-HT3 Receptor Blockers. In: StatPearls. StatPearls Publishing 2023 n.d.\u00a0http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513318\/. Accessed 21 Jun 2023"},{"key":"274_CR195","unstructured":"T Ng V Gupta MC Keshock. Tetrahydrocannabinol (THC). In: StatPearls StatPearls Publishing 2023 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563174\/. Accessed 22 Jun 2023"},{"issue":"1","key":"274_CR196","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"T Sugiura, S Kondo, A Sukagawa. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun. 1995;215(1):89-97 https:\/\/doi.org\/10.1006\/bbrc.1995.2437","journal-title":"Biochem Biophys Res Commun"},{"key":"274_CR197","unstructured":"Tissue expression of TRPV1 - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000196689-TRPV1\/tissue. Accessed 22 Jan 2023."},{"key":"274_CR198","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.reprotox.2016.09.016","volume":"66","author":"GM Tiboni","year":"2016","unstructured":"Tiboni GM, Ponzano A. Fetal safety profile of aromatase inhibitors: Animal data. Reprod Toxicol. 2016;66:84\u201392. https:\/\/doi.org\/10.1016\/j.reprotox.2016.09.016.","journal-title":"Reprod Toxicol"},{"key":"274_CR199","unstructured":"TRPV3 protein expression summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000167723-TRPV3. Accessed 19 Jul 2023"},{"key":"274_CR200","unstructured":"TRPM8 protein expression summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000144481-TRPM8. Accessed 19 Jul 2023"},{"key":"274_CR201","unstructured":"Tissue expression of CNR1 - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000118432-CNR1\/tissue. Accessed 25 Oct 2023"},{"key":"274_CR202","unstructured":"Tissue expression of PPARG - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000132170-PPARG\/tissue. Accessed 22 Jan 2023"},{"key":"274_CR203","unstructured":"Tissue expression of CNR2 - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000188822-CNR2\/tissue. Accessed 25 Oct 2023"},{"key":"274_CR204","unstructured":"Tissue expression of HTR1A - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000178394-HTR1A\/tissue. Accessed 25 Jan 2023"},{"key":"274_CR205","unstructured":"Tissue expression of GPR3 - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000181773-GPR3\/tissue. Accessed 19 Jul 2023"},{"key":"274_CR206","doi-asserted-by":"publisher","unstructured":"Tour J, Sandstr\u00f6m A, Kadetoff D, Schalling M, Kosek E. The OPRM1 gene and interactions with the 5-HT1a gene regulate conditioned pain modulation in fibromyalgia patients and healthy controls. PLoS ONE. 2022;17(11). https:\/\/doi.org\/10.1371\/journal.pone.0277427.","DOI":"10.1371\/journal.pone.0277427"},{"key":"274_CR207","unstructured":"TRPA1 protein expression summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000104321-TRPA1. Accessed 19 Jul 2023"},{"key":"274_CR208","unstructured":"Tissue expression of GPR6 - Summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000146360-GPR6\/tissue. Accessed 19 Jul 2023"},{"key":"274_CR209","unstructured":"TRPV4 protein expression summary - The Human Protein Atlas n.d https:\/\/www.proteinatlas.org\/ENSG00000111199-TRPV4. Accessed 19 Jul 2023."},{"issue":"8","key":"274_CR210","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0006-3223(92)90311-m","volume":"31","author":"RD Todd","year":"1992","unstructured":"Todd RD. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry. 1992;31(8):794\u2013807. https:\/\/doi.org\/10.1016\/0006-3223(92)90311-m.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"274_CR211","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2007","unstructured":"Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007;150(5):613\u201323. https:\/\/doi.org\/10.1038\/sj.bjp.0707133.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"274_CR212","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/can.2015.0012","volume":"1","author":"I Ujv\u00e1ry","year":"2016","unstructured":"Ujv\u00e1ry I, Hanu\u0161 L. Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res. 2016;1(1):90\u2013101. https:\/\/doi.org\/10.1089\/can.2015.0012.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"9","key":"274_CR213","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.3390\/ijms22094876","volume":"22","author":"RM Vitale","year":"2021","unstructured":"Vitale RM, Iannotti FA, Amodeo P. The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets. Int J Mol Sci. 2021;22(9):4876. https:\/\/doi.org\/10.3390\/ijms22094876.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"274_CR214","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0022-5347(25)00276-9","volume":"241","author":"PJ Vaysse","year":"1987","unstructured":"Vaysse PJ, Gardner EL, Zukin RS. Modulation of rat brain opioid receptors by cannabinoids. J Pharmacol Exp Ther. 1987;241(2):534\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"274_CR215","doi-asserted-by":"publisher","unstructured":"Valverde O, C\u00e9l\u00e9rier E, Baranyi M, et al. GPR3 Receptor, a Novel Actor in the Emotional-Like Responses. PLoS ONE. 2009;4(3). https:\/\/doi.org\/10.1371\/journal.pone.0004704.","DOI":"10.1371\/journal.pone.0004704"},{"issue":"1","key":"274_CR216","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1038\/s41598-021-84879-2","volume":"11","author":"TAM Vrechi","year":"2021","unstructured":"Vrechi TAM, Le\u00e3o AHFF, Morais IBM, et al. Cannabidiol induces autophagy via ERK1\/2 activation in neural cells. Sci Rep. 2021;11(1):5434. https:\/\/doi.org\/10.1038\/s41598-021-84879-2.","journal-title":"Sci Rep"},{"issue":"23","key":"274_CR217","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1128\/MCB.24.23.10340-10351.2004","volume":"24","author":"ER Vickers","year":"2004","unstructured":"Vickers ER, Kasza A, Kurnaz IA, et al. Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death. Mol Cell Biol. 2004;24(23):10340\u201351. https:\/\/doi.org\/10.1128\/MCB.24.23.10340-10351.2004.","journal-title":"Mol Cell Biol"},{"key":"274_CR218","doi-asserted-by":"publisher","first-page":"777804","DOI":"10.3389\/fphar.2021.777804","volume":"12","author":"KB Walsh","year":"2021","unstructured":"Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol. 2021;12:777804. https:\/\/doi.org\/10.3389\/fphar.2021.777804.","journal-title":"Front Pharmacol"},{"issue":"2","key":"274_CR219","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1124\/jpet.109.156380","volume":"331","author":"L Wang","year":"2009","unstructured":"Wang L, Martin B, Brenneman R, Luttrell LM, Maudsley S. Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders. J Pharmacol Exp Ther. 2009;331(2):340\u20138. https:\/\/doi.org\/10.1124\/jpet.109.156380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"14","key":"274_CR220","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.3390\/jcm12144620","volume":"12","author":"M Wici\u0144ski","year":"2023","unstructured":"Wici\u0144ski M, Fajkiel-Madajczyk A, Kurant Z, et al. The Use of Cannabidiol in Metabolic Syndrome\u2014An Opportunity to Improve the Patient\u2019s Health or Much Ado about Nothing? J Clin Med. 2023;12(14):4620. https:\/\/doi.org\/10.3390\/jcm12144620.","journal-title":"J Clin Med"},{"issue":"(6)","key":"274_CR221","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms21062061","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, Nakajima T, Gonzalez FJ, Tanaka N. PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. Int J Mol Sci. 2020;21((6)):2061. https:\/\/doi.org\/10.3390\/ijms21062061.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"274_CR222","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/cancers6031500","volume":"6","author":"R Wisastra","year":"2014","unstructured":"Wisastra R, Dekker FJ. Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked. Cancers (Basel). 2014;6(3):1500\u201321. https:\/\/doi.org\/10.3390\/cancers6031500.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"274_CR223","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tox.2004.08.005","volume":"206","author":"K Watanabe","year":"2005","unstructured":"Watanabe K, Motoya E, Matsuzawa N, et al. Marijuana extracts possess the effects like the endocrine disrupting chemicals. Toxicology. 2005;206(3):471\u20138. https:\/\/doi.org\/10.1016\/j.tox.2004.08.005.","journal-title":"Toxicology"},{"issue":"27","key":"274_CR224","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1523\/JNEUROSCI.1405-05.2005","volume":"25","author":"J Wu","year":"2005","unstructured":"Wu J, Hablitz JJ. Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer I interneurons. J Neurosci. 2005;25(27):6322. https:\/\/doi.org\/10.1523\/JNEUROSCI.1405-05.2005.","journal-title":"J Neurosci"},{"issue":"1","key":"274_CR225","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/19336950.2019.1615824","volume":"13","author":"AR Watkins","year":"2019","unstructured":"Watkins AR. Cannabinoid interactions with ion channels and receptors. Channels (Austin). 2019;13(1):162\u20137. https:\/\/doi.org\/10.1080\/19336950.2019.1615824.","journal-title":"Channels (Austin)"},{"key":"274_CR226","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2011.03.066","volume":"184","author":"W Xiong","year":"2011","unstructured":"Xiong W, Koo BN, Morton R, Zhang L. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT3A receptors through a receptor desensitization-dependent mechanism. Neuroscience. 2011;184:28\u201337. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.03.066.","journal-title":"Neuroscience"},{"issue":"17","key":"274_CR227","doi-asserted-by":"publisher","first-page":"14884","DOI":"10.1074\/jbc.M111718200","volume":"277","author":"YQ Xiao","year":"2002","unstructured":"Xiao YQ, Malcolm K, Worthen GS, et al. Cross-talk between ERK and p38 MAPK Mediates Selective Suppression of Pro-inflammatory Cytokines by Transforming Growth Factor-\u03b2 *. J Biol Chem. 2002;277(17):14884\u201393. https:\/\/doi.org\/10.1074\/jbc.M111718200.","journal-title":"J Biol Chem"},{"issue":"2","key":"274_CR228","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI1368","volume":"101","author":"Z Xing","year":"1998","unstructured":"Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101(2):311\u201320.","journal-title":"J Clin Invest"},{"issue":"15\u201316","key":"274_CR229","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.lfs.2011.02.017","volume":"88","author":"S Yamaori","year":"2011","unstructured":"Yamaori S, Ebisawa J, Okushima Y, Yamamoto I, Watanabe K. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Life Sci. 2011;88(15\u201316):730\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2011.02.017.","journal-title":"Life Sci"},{"issue":"11","key":"274_CR230","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1124\/dmd.111.041384","volume":"39","author":"S Yamaori","year":"2011","unstructured":"Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos. 2011;39(11):2049\u201356. https:\/\/doi.org\/10.1124\/dmd.111.041384.","journal-title":"Drug Metab Dispos"},{"key":"274_CR231","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lfs.2015.07.007","volume":"136","author":"S Yamaori","year":"2015","unstructured":"Yamaori S, Kinugasa Y, Jiang R, Takeda S, Yamamoto I, Watanabe K. Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells. Life Sci. 2015;136:87\u201393. https:\/\/doi.org\/10.1016\/j.lfs.2015.07.007.","journal-title":"Life Sci"},{"issue":"1","key":"274_CR232","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1038\/s41598-023-32927-4","volume":"13","author":"A Yndart Arias","year":"2023","unstructured":"Yndart Arias A, Kolishetti N, Vashist A, Madepalli L, Llaguno L, Nair M. Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1. Sci Rep. 2023;13(1):7376. https:\/\/doi.org\/10.1038\/s41598-023-32927-4.","journal-title":"Sci Rep"},{"key":"274_CR233","doi-asserted-by":"publisher","first-page":"352371","DOI":"10.1155\/2014\/352371","volume":"2014","author":"Y Yang","year":"2014","unstructured":"Yang Y, Kim SC, Yu T, et al. Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses. Mediators Inflamm. 2014;2014:352371. https:\/\/doi.org\/10.1155\/2014\/352371.","journal-title":"Mediators Inflamm"},{"key":"274_CR234","doi-asserted-by":"publisher","first-page":"841290","DOI":"10.3389\/fimmu.2022.841290","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan J, Chen L, Wang J, et al. Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation Through the Inhibition of STAT3\/YKL-40 Axis in Mice With Chronic Cerebral Hypoperfusion-induced White Matter Lesions. Front Immunol. 2022;13:841290. https:\/\/doi.org\/10.3389\/fimmu.2022.841290.","journal-title":"Front Immunol"},{"issue":"2","key":"274_CR235","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/jpet.109.162594","volume":"333","author":"KH Yang","year":"2010","unstructured":"Yang KH, Galadari S, Isaev D, Petroianu G, Shippenberg TS, Oz M. The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes. J Pharmacol Exp Ther. 2010;333(2):547\u201354. https:\/\/doi.org\/10.1124\/jpet.109.162594.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"274_CR236","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","volume":"79","author":"S Yamaori","year":"2010","unstructured":"Yamaori S, Kushihara M, Yamamoto I, Watanabe K. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. Biochem Pharmacol. 2010;79(11):1691\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2010.01.028.","journal-title":"Biochem Pharmacol"},{"key":"274_CR237","doi-asserted-by":"publisher","unstructured":"HXB Zhang, L Heckman, Z Niday. Cannabidiol activates neuronal Kv7 channels. eLife. 2022; 11:e73246. https:\/\/doi.org\/10.7554\/eLife.73246","DOI":"10.7554\/eLife.73246"},{"key":"274_CR238","doi-asserted-by":"crossref","unstructured":"U Zanger, K Klein. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet. 2013;4.\u00a0https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2013.00024. Accessed 19 Jul 2023.","DOI":"10.3389\/fgene.2013.00024"},{"issue":"23","key":"274_CR239","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ma J, Li M, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22(23):12808. https:\/\/doi.org\/10.3390\/ijms222312808.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"274_CR240","doi-asserted-by":"publisher","first-page":"e2254752","DOI":"10.1001\/jamanetworkopen.2022.54752","volume":"6","author":"CA Zamarripa","year":"2023","unstructured":"Zamarripa CA, Spindle TR, Surujunarain R, et al. Assessment of Orally Administered \u03949-Tetrahydrocannabinol When Coadministered With Cannabidiol on \u03949-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e2254752. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54752.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"274_CR241","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/138920009789895552","volume":"10","author":"SF Zhou","year":"2009","unstructured":"Zhou SF, Yang LP, Wei MQ, Duan W, Chan E. Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr Drug Metab. 2009;10(7):713\u201329. https:\/\/doi.org\/10.2174\/138920009789895552.","journal-title":"Curr Drug Metab"},{"key":"274_CR242","doi-asserted-by":"publisher","first-page":"174829","DOI":"10.1016\/j.ejphar.2022.174829","volume":"919","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li H, Jin S, et al. Cannabidiol protects against Alzheimer\u2019s disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups. Eur J Pharmacol. 2022;919:174829. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174829.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"274_CR243","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou S, Kumar U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int J Mol Sci. 2018;19(3):833. https:\/\/doi.org\/10.3390\/ijms19030833.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00274-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T09:04:31Z","timestamp":1747213471000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00274-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":243,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00274-y","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}